Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Operating Expenses | 4,920 | 4,640 | 7,405 | 7,866 | 6,873 |
| Operating Income | -4,920 | -4,640 | -7,405 | -7,866 | -6,873 |
| Interest Expense | 0 | 1 | 2 | 6 | 0 |
| Other Income | -1,621 | 694 | -58 | 4,796 | 1,447 |
| Pre-tax Income | -6,541 | -3,946 | -7,464 | -3,075 | -5,426 |
| Net Income Continuous | -6,541 | -3,946 | -7,464 | -3,075 | -5,426 |
| Net Income | $-6,541 | $-3,946 | $-7,464 | $-3,075 | $-5,426 |
| EPS Basic Total Ops | -4.80 | -3.00 | -6.01 | -2.70 | -5.11 |
| EPS Basic Continuous Ops | -4.78 | -2.88 | -6.12 | -2.78 | -4.90 |
| EPS Diluted Total Ops | -4.80 | -3.00 | -6.01 | -2.70 | -3.90 |
| EPS Diluted Continuous Ops | -4.78 | -2.88 | -6.12 | -2.78 | -3.75 |
| EBITDA(a) | $-4,910 | $-4,623 | $-7,388 | $-7,855 | $-6,859 |